drugset / Trial / NCT00146900

Prevention of Post Traumatic Stress Disorder by Early Treatment

NCT00146900

Completed 298 enrolled Hadassah Medical Organization
RandomizedParallel-groupSingle-blindPrevention

Summary

To prospectively evaluate the effect of early treatment (cognitive therapy (CT), cognitive-behavioral therapy (CBT) and escitalopram (SSRI) in preventing the occurrence of post-traumatic stress disorder in recent survivors of traumatic events.

Timeline

Start
2004-08
Primary completion
2008-01
Completion
2008-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 20 mg